SCHEMBL26495437

SCHEMBL26495437

CN(CCCCO)CCCCC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.62
FFAR1 O14842 1/20 0.62
FFAR4 Q5NUL3 1/20 0.62
CAMK2A Q9UQM7 1/20 0.54
KDM4C Q9H3R0 10/20 0.51
KDM5A P29375 8/20 0.51
KDM5C P41229 1/20 0.51
KDM5B Q9UGL1 1/20 0.51
PHF8 Q9UPP1 2/20 0.50
KDM4A O75164 2/20 0.50
LMNA P02545 2/20 0.48
TSHR P16473 2/20 0.46
NFKB1 P19838 1/20 0.46
PMP22 Q01453 1/20 0.46
AKR1B1 P15121 1/20 0.44
ALDH1A1 P00352 1/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
PPARG P37231 1/20 0.43
PPARD Q03181 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26495498 0.98 GPR84 (0.67) GPR84FFAR1FFAR4CAMK2AKDM4C
SCHEMBL26495567 0.98 GPR84 (0.67) GPR84FFAR1FFAR4CAMK2AKDM4C
SCHEMBL26495628 0.98 GPR84 (0.67) GPR84FFAR1FFAR4CAMK2AKDM4C
SCHEMBL26495428 0.96 GPR84 (0.56) GPR84FFAR1FFAR4CAMK2AKDM4C
SCHEMBL26495396 0.96 GPR84 (0.56) GPR84FFAR1FFAR4CAMK2AKDM4C
SCHEMBL26495563 0.94 GPR84 (0.60) GPR84FFAR1FFAR4CAMK2AKDM4C
SCHEMBL26495495 0.94 GPR84 (0.60) GPR84FFAR1FFAR4CAMK2AKDM4C
SCHEMBL14569694 0.94 GPR84 (0.60) GPR84FFAR1FFAR4CAMK2AKDM4C
SCHEMBL26495422 0.91 KDM4C (0.51) GPR84FFAR1FFAR4CAMK2AKDM4C
SCHEMBL12051225 0.89 GPR84 (0.54) GPR84FFAR1FFAR4KDM4CKDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320995-A1 IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES CAPSTAN THERAPEUTICS, INC. (US) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320995-A1 IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES PLTP, LNPEP, PLIN3 GPR84 2808/4885FFAR1 1062/4885FFAR4 822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.